ArticleMolecular therapy. Nucleic acids2020

A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation.

Yanqiong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.